New Jersey A 1816: Requires hospitals to test for fentanyl and xylazine as part of urine drug screenings.

Status: Introduced, Referred to Assembly Health Committee (as of 2026-01-13)

State: New Jersey · Session: 222 · Bill: A 1816

Sponsors: Fantasia, Dawn, Verrelli, Anthony S., Speight, Shanique, Tully, Chris

View New Jersey A 1816 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.